Package 25021-471-74

Brand: fulvestrant

Generic: fulvestrant
NDC Package

Package Facts

Identity

Package NDC 25021-471-74
Digits Only 2502147174
Product NDC 25021-471
Description

2 SYRINGE in 1 CARTON (25021-471-74) / 5 mL in 1 SYRINGE

Marketing

Marketing Status
Marketed Since 2024-09-15
Brand fulvestrant
Generic fulvestrant
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR"], "spl_id": "fe82b170-2347-474e-93cb-c4fe66d1834e", "openfda": {"nui": ["N0000175582", "N0000000145", "N0000000168"], "unii": ["22X328QOC4"], "rxcui": ["727762"], "spl_set_id": ["0f05b699-c440-42c1-9557-46759a10ab17"], "pharm_class_epc": ["Estrogen Receptor Antagonist [EPC]"], "pharm_class_moa": ["Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE in 1 CARTON (25021-471-74)  / 5 mL in 1 SYRINGE", "package_ndc": "25021-471-74", "marketing_start_date": "20240915"}], "brand_name": "fulvestrant", "product_id": "25021-471_fe82b170-2347-474e-93cb-c4fe66d1834e", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Estrogen Receptor Antagonist [EPC]", "Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "product_ndc": "25021-471", "generic_name": "fulvestrant", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "fulvestrant", "active_ingredients": [{"name": "FULVESTRANT", "strength": "50 mg/mL"}], "application_number": "ANDA211422", "marketing_category": "ANDA", "marketing_start_date": "20240915", "listing_expiration_date": "20261231"}